MediciNova, Inc.
MediciNova, Inc. (MNOV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MNOV · as of Jun 9, 2026
Key Statistics
Explore MediciNova, Inc. Data
mnov stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
Competitors & Peers
mnov competitorsMNOV
ACRV
BMEA
CBUS
FBIO
IMUXStock Performance
Full HistoryAbout MediciNova, Inc.
MediciNova, Inc. is a biopharmaceutical firm dedicated to discovering and advancing innovative small molecule therapies for severe illnesses where current treatments are insufficient within the United…
what is medicinova, inc. · mnov stock overview · medicinova, inc. company profile · who is medicinova, inc. ceo · mnov NASDAQ · medicinova, inc. headquarters · medicinova, inc. business segments
About Stock Overview & Key Data
MediciNova, Inc. (MNOV) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 8, 2006. As of the latest trading session, MNOV stock price is $1.30, with a market capitalization of $64.0M. The stock has returned -8.45% over the past 12 months and -0.76% year-to-date.
According to 4 Wall Street analysts, the consensus rating for MediciNova, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, MediciNova, Inc. reported revenue of $409657.00 and net income of -$12.0M. For detailed data — including MediciNova, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, MediciNova, Inc. (MNOV) stock price is $1.30. The stock is traded on NASDAQ under the ticker symbol MNOV. The 52-week range is $1.17 – $1.96.